Evidence map›Paper›PMID 27547766›Full record

ReviewJournal of diabetes research2016

The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification.

Amber M Kay, C LaShan Simpson, James A Stewart

Open access · goldAbstract readReview
In one paragraph

Review in Journal of diabetes research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 2 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 2 syntheses or guidelines pooled it, 337 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amber M KayDepartment of Biological Sciences, Mississippi State University, Mississippi State, MS 39762, USA.ORCID 0000-0002-0423-6526
C LaShan SimpsonDepartment of Agricultural and Biological Engineering, Mississippi State University, Mississippi State, MS 39762, USA.ORCID 0000-0002-2908-7977
James A StewartDepartment of Biological Sciences, Mississippi State University, Mississippi State, MS 39762, USA.ORCID 0000-0001-6024-6297
Mississippi State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AGE/RAGE signaling has been a well-studied cascade in many different disease states, particularly diabetes. Due to the complex nature of the receptor and multiple intersecting pathways, the AGE/RAGE signaling mechanism is still not well understood. The purpose of this review is to highlight key areas of AGE/RAGE mediated vascular calcification as a complication of diabetes. AGE/RAGE signaling heavily influences both cellular and systemic responses to increase bone matrix proteins through PKC, p38 MAPK, fetuin-A, TGF-β, NFκB, and ERK1/2 signaling pathways in both hyperglycemic and calcification conditions. AGE/RAGE signaling has been shown to increase oxidative stress to promote diabetes-mediated vascular calcification through activation of Nox-1 and decreased expression of SOD-1. AGE/RAGE signaling in diabetes-mediated vascular calcification was also attributed to increased oxidative stress resulting in the phenotypic switch of VSMCs to osteoblast-like cells in AGEs-induced calcification. Researchers found that pharmacological agents and certain antioxidants decreased the level of calcium deposition in AGEs-induced diabetes-mediated vascular calcification. By understanding the role the AGE/RAGE signaling cascade plays diabetes-mediated vascular calcification will allow for pharmacological intervention to decrease the severity of this diabetic complication.

Indexed as

alpha-2-HS-GlycoproteinDiabetes Mellitus, Type 2Glycation End Products, AdvancedHumansMAP Kinase Signaling SystemNADPH Oxidase 1NADPH OxidasesNF-kappa BOxidative Stressp38 Mitogen-Activated Protein KinasesProtein Kinase CReceptor for Advanced Glycation End ProductsSignal TransductionSuperoxide Dismutase-1Transforming Growth Factor betaVascular Calcificationalpha-2-HS-GlycoproteinGlycation End Products, AdvancedNADPH Oxidase 1NADPH OxidasesNF-kappa BNOX1 protein, humanp38 Mitogen-Activated Protein KinasesProtein Kinase CReceptor for Advanced Glycation End ProductsSOD1 protein, humanSuperoxide Dismutase-1Transforming Growth Factor beta

Identifiers

PMID27547766
PMCPMC4980539
OpenAlexW2501497123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.